Patents by Inventor Gary Dukart

Gary Dukart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor activity of CCI-779 in papillary renal cell cancer
    Patent number: 8791097
    Abstract: This invention provides the method or use of CCI-779 in the treatment of papillary renal cell carcinoma.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: July 29, 2014
    Assignee: Wyeth LLC
    Inventors: Gary Dukart, James Joseph Gibbons, Jr., Anna Berkenblit, Jay Marshall Feingold
  • Use of CCI-779 as an antineoplastic agent
    Patent number: 7781446
    Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.
    Type: Grant
    Filed: February 1, 2007
    Date of Patent: August 24, 2010
    Assignee: Wyeth LLC
    Inventors: Gary Dukart, James J. Gibbons, Jr., Lisa Anne Speicher, Philip Frost, Carolyn Mary Discafani-Marro
  • Method of potentiating chemotherapy and treating solid tumors
    Patent number: 7465754
    Abstract: This invention provides a method of treating solid tumors which comprises administering an effective amount of a combination of (1) a bioresponse modifier and (2) a chemotherapeutic agent. This invention also provides a method of potentiating the effects of a chemotherapeutic regimen in a mammal in need of treatment with such regimen which comprises administering a bioresponse modifier in addition to a chemotherapeutic regimen.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: December 16, 2008
    Assignee: Wyeth
    Inventors: James J. Gibbons, Jr., Gary Dukart, Judy Lucas, Lisa A. Speicher
  • ANTI-TUMOR ACTIVITY OF CCI-779 IN PAPILLARY RENAL CELL CANCER
    Publication number: 20080255177
    Abstract: This invention provides the method or use of CCI-779 in the treatment of papillary renal cell carcinoma.
    Type: Application
    Filed: April 8, 2008
    Publication date: October 16, 2008
    Applicant: Wyeth
    Inventors: GARY DUKART, James Joseph Gibbons, Anna Berkenblit, Jay Marshall Feingold
  • Use of CCI-779 as an antineoplastic agent
    Publication number: 20070142425
    Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.
    Type: Application
    Filed: February 1, 2007
    Publication date: June 21, 2007
    Applicant: Wyeth
    Inventors: Gary Dukart, James Gibbons, Lisa Speicher, Philip Frost, Carolyn Discafani-Marro
  • Use of CCI-779 as an antineoplastic agent
    Patent number: 7189735
    Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: March 13, 2007
    Assignee: Wyeth
    Inventors: Gary Dukart, James J Gibbons, Jr., Lisa A Speicher, Philip Frost, Carolyn M Discafani-Marro
  • Antineoplastic combinations
    Publication number: 20060035904
    Abstract: This invention provides the use of a combination of an mTOR inhibitor and an antimetabolite antineoplastic agent in the treatment of neoplasms.
    Type: Application
    Filed: September 29, 2005
    Publication date: February 16, 2006
    Applicant: Wyeth
    Inventors: Jurgen Frisch, James Gibbons, Gary Dukart
  • Antineoplastic combinations
    Publication number: 20060030547
    Abstract: This invention provides the use of a combination of CCI-779 and an antineoplastic alkylating agent in the treatment of neoplasms.
    Type: Application
    Filed: October 12, 2005
    Publication date: February 9, 2006
    Applicant: Wyeth
    Inventors: Gary Dukart, James Gibbons
  • Antineoplastic combinations
    Publication number: 20050187184
    Abstract: This invention provides the use of a combination of CCI-779 and an antimetabolite antineoplastic agent in the treatment of neoplasms.
    Type: Application
    Filed: April 20, 2005
    Publication date: August 25, 2005
    Applicant: Wyeth
    Inventors: James Gibbons, Gary Dukart, Jurgen Frisch
  • Antineoplastic agents
    Publication number: 20040258662
    Abstract: This invention provides the use of a combination of CCI-779 and interferon alfa (&agr;) in the treatment of neoplasms.
    Type: Application
    Filed: April 14, 2004
    Publication date: December 23, 2004
    Applicant: Wyeth
    Inventors: James J. Gibbons, Gary Dukart, Matthew L. Sherman
  • Use of CCI-779 as an antineoplastic agent
    Publication number: 20030153593
    Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.
    Type: Application
    Filed: February 26, 2003
    Publication date: August 14, 2003
    Applicant: Wyeth
    Inventors: Gary Dukart, James J. Gibbons, Lisa A. Speicher, Philip Frost, Carolyn M. Discafani-Marro
  • Antineoplastic combinations
    Publication number: 20030008923
    Abstract: This invention provides the use of a combination of an mTOR inhibitor and an antineoplastic alkylating agent in the treatment of neoplasms.
    Type: Application
    Filed: May 29, 2002
    Publication date: January 9, 2003
    Applicant: Wyeth
    Inventors: Gary Dukart, James Joseph Gibbons
  • Antineoplastic combinations
    Publication number: 20020198137
    Abstract: This invention provides the use of a combination of CCI-779 and an antineoplastic alkylating agent in the treatment of neoplasms.
    Type: Application
    Filed: May 29, 2002
    Publication date: December 26, 2002
    Applicant: Wyeth
    Inventors: Gary Dukart, James Joseph Gibbons
  • Antineoplastic combinations
    Publication number: 20020183240
    Abstract: This invention provides the use of a combination of CCI-779 and an antimetabolite antineoplastic agent in the treatment of neoplasms.
    Type: Application
    Filed: April 5, 2002
    Publication date: December 5, 2002
    Applicant: Wyeth
    Inventors: James J. Gibbons, Gary Dukart, Jurgen Frisch
  • Antineoplastic combinations
    Publication number: 20020183239
    Abstract: This invention provides the use of a combination of an mTOR inhibitor and an antimetabolite antineoplastic agent in the treatment of neoplasms.
    Type: Application
    Filed: April 5, 2002
    Publication date: December 5, 2002
    Applicant: Wyeth
    Inventors: James J. Gibbons, Gary Dukart, Jurgen Frisch
  • Use of CCI-779 as an antineoplastic agent
    Publication number: 20020091137
    Abstract: This invention provides the use of CCl-779 in the treatment of neoplasms.
    Type: Application
    Filed: November 13, 2001
    Publication date: July 11, 2002
    Applicant: American Home Products Corporation
    Inventors: Gary Dukart, James J. Gibbons, Lisa A. Speicher, Philip Frost, Carolyn M. Discafani-Marro